TITLE

Prevention of Diabetes With Pioglitazone in ACT NOW

AUTHOR(S)
DeFronzo, Ralph A.; Tripathy, Devjit; Schwenke, Dawn C.; Banerji, MaryAnn; Bray, George A.; Buchanan, Thomas A.; Clement, Stephen C.; Gastaldelli, Amalia; Henry, Robert R.; Kitabchi, Abbas E.; Mudaliar, Sunder; Ratner, Robert E.; Stentz, Frankie B.; Musi, Nicolas; Reaven, Peter D.
PUB. DATE
November 2013
SOURCE
Diabetes;Nov2013, Vol. 62 Issue 11, p3920
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We examined the metabolic characteristics that attend the development of type 2 diabetes (T2DM) in 441 impaired glucose tolerance (IGT) subjects who participated in the ACT NOW Study and had complete end-of-study metabolic measurements. Subjects were randomized to receive pioglitazone (PGZ; 45 mg/day) or placebo and were observed for a median of 2.4 years. Indices of insulin sensitivity (Matsuda index [MI]), insulin secretion (IS)/insulin resistance (IR; ΔI0-120/ΔG0-120, ΔIS rate [ISR]0-120/ΔG0-120), and β-cell function (ΔI/ΔG x MI and ΔISR/ΔG x MI) were calculated from plasma glucose, insulin, and C-peptide concentrations during oral glucose tolerance tests at baseline and study end. Diabetes developed in 45 placebo-treated vs. 15 PGZ-treated subjects (odds ratio [OR] 0.28 [95% CI 0.15-0.49]; P < 0.0001); 48% of PGZ-treated subjects reverted to normal glucose tolerance (NGT) versus 28% of placebo-treated subjects (P < 0.005). Higher final glucose tolerance status (NGT > IGT > T2DM) was associated with improvements in insulin sensitivity (OR 0.61 [95% CI 0.54-0.80]), IS (OR 0.61 [95% CI 0.50-0.75]), and β-cell function (ln IS/IR index and ln ISR/IR index) (OR 0.26 [95% CI 0.19-0.37]; all P < 0.0001). Of the factors measured, improved β-cell function was most closely associated with final glucose tolerance status.
ACCESSION #
92597495

 

Related Articles

  • Effects of a Flaxseed-Derived Lignan Supplement in Type 2 Diabetic Patients: A Randomized, Double-Blind, Cross-Over Trial. An Pan; Jianqin Sun; Yanqiu Chen; Xingwang Ye; Huaixing Li; Zhijie Yu; Yanfang Wang; Wenjia Gu; Xinyi Zhang; Xiafei Chen; Demark-Wahnefried, Wendy; Yong Liu; Xu Lin // PLoS Clinical Trials;Nov2007, Vol. 4 Issue 11, p1 

    Background. Flaxseed consumption has been shown to improve blood lipids in humans and flaxseed-derived lignan has been shown to enhance glycemic control in animals. The study aimed to investigate the effect of a flaxseed-derived lignan supplement on glycemic control, lipid profiles and insulin...

  • Long-Term Effects of Bariatric Surgery on Meal Disposal and β-Cell Function in Diabetic and Nondiabetic Patients. Camastra, Stefania; Muscelli, Elza; Gastaldelli, Amalia; Holst, Jens J.; Astiarraga, Brenno; Baldi, Simona; Nannipieri, Monica; Ciociaro, Demetrio; Anselmino, Marco; Mari, Andrea; Ferrannini, Ele // Diabetes;Nov2013, Vol. 62 Issue 11, p3709 

    Gastric bypass surgery leads to marked improvements in glucose tolerance and insulin sensitivity in obese type 2 diabetes (T2D); the impact on glucose fluxes in response to a physiological stimulus, such as a mixed meal test (MTT), has not been determined. We administered an MTT to 12 obese T2D...

  • Dual Mechanism for Type-2 Diabetes Resolution after Roux-en-Y Gastric Bypass. LIN, EDWARD; DAVIS, S. SCOTT; SRINIVASAN, JAHNAVI; SWEENEY, JOHN F.; ZIEGLER, THOMAS R.; PHILLIPS, LAWRENCE; GLETSU-MILLER, NANA // American Surgeon;Jun2009, Vol. 75 Issue 6, p498 

    Resolution of Type-2 diabetes mellitus (DM) after weight toss surgery is well documented, but the mechanism is elusive. We evaluated the glucose-insulin metabolism of patients undergoing a Roux-en-Y gastric bypass (RYGB) using the intravenous glucose tolerance test (IVGTT) and compared it with...

  • Methods and Models for Metabolic Assessment in Mice. Pacini, G.; Omar, B.; Ahrén, B. // Journal of Diabetes Research;2013, p1 

    The development of new therapies for the treatment of type 2 diabetes requires robust, reproducible and well validated in vivo experimental systems. Mice provide the most ideal animal model for studies of potential therapies. Unlike larger animals, mice have a short gestational period, are...

  • Effects of 16-Week Consumption of Caffeinated and Decaffeinated Instant Coffee on Glucose Metabolism in a Randomized Controlled Trial. Keizo Ohnaka; Mizuko Ikeda; Takako Maki; Tomoko Okada; Takao Shimazoe; Masahiro Adachi; Masatoshi Nomura; Ryoichi Takayanagi; Suminori Kono // Journal of Nutrition & Metabolism;2012, p1 

    Objective. Observational studies have shown a protective association between coffee consumption and type 2 diabetes mellitus whereas caffeine or caffeinated coffee acutely deteriorates glucose tolerance. We investigated the effects of chronic drinking of instant coffee on glucose and insulin...

  • Effect of Folic Acid Supplementation on Indices of Glycemic Control, Insulin Resistance and Lipid Profile in Patients With Type 2 Diabetes Mellitus. Aghamohammadi khiavi, V.; Pourghassem Gargari, B.; Aliasgharzadeh, A. // Iranian Journal of Endocrinology & Metabolism;Nov2011, Vol. 13 Issue 4, p424 

    Introduction: This study was performed to determine the effects of supplementation of folate on indices of glycemic control, insulin resistance and lipid profile in in men with type 2 diabetes, under metformin (at least 1500mg daily) treatment. Materials and Methods: This was a double-blind...

  • Light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trial. Brouwer, Annelies; van Raalte, Daniël H.; Diamant, Michaela; Rutters, Femke; van Someren, Eus J. W.; Snoek, Frank J.; Beekman, Aartjan T. F.; Bremmer, Marijke A. // BMC Psychiatry;2015, Vol. 15 Issue 1, p1 

    Background: Major depression and type 2 diabetes often co-occur. Novel treatment strategies for depression in type 2 diabetes patients are warranted, as depression in type 2 diabetes patients is associated with poor prognosis and treatment results. Major depression and concurrent sleep disorders...

  • Esculentin-2CHa-Related Peptides Modulate Islet Cell Function and Improve Glucose Tolerance in Mice with Diet-Induced Obesity and Insulin Resistance. Ojo, Opeolu O.; Srinivasan, Dinesh K.; Owolabi, Bosede O.; Vasu, Srividya; Conlon, J. Michael; Flatt, Peter R.; Abdel-Wahab, Yasser H. A. // PLoS ONE;29/10/2015, Vol. 10 Issue 10, p1 

    The frog skin host-defense peptide esculentin-2CHa (GFSSIFRGVA10KFASKGLGK D20LAKLGVDLVA30CKISKQC) displays antimicrobial, antitumor, and immunomodulatory properties. This study investigated the antidiabetic actions of the peptide and selected analogues. Esculentin-2CHa stimulated insulin...

  • Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model. Amrutkar, Manoj; Cansby, Emmelie; Chursa, Urszula; Nuñez-Durán, Esther; Chanclón, Belén; Ståhlman, Marcus; Fridén, Vincent; Mannerås-Holm, Louise; Wickman, Anna; Smith, Ulf; Bäckhed, Fredrik; Borén, Jan; Howell, Brian W.; Mahlapuu, Margit // Diabetes;Aug2015, Vol. 64 Issue 8, p2791 

    Understanding the molecular networks controlling ectopic lipid deposition, glucose tolerance, and insulin sensitivity is essential to identifying new pharmacological approaches to treat type 2 diabetes. We recently identified serine/threonine protein kinase 25 (STK25) as a negative regulator of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics